Mount Sinai Hospital; Oncology
Toronto, Ontario, Canada
Oncologist in Toronto, Ontario
600 University Ave, Toronto, ON M5G 1X5
About Mount Sinai Hospital; Oncology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Mount Sinai Hospital; Oncology
During the past decade, Mount Sinai Hospital; Oncology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
2013-04-01
2030-01-01
Active, not recruiting
1,900
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
2013-12-13
Active, not recruiting
1,473
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
2013-12-23
2023-07-01
Active, not recruiting
488
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
2014-08-18
Recruiting
8,300
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
2014-07-22
2023-12-31
Active, not recruiting
280
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
2014-08-18
2036-05-01
Recruiting
168
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
2015-07-13
2023-10-02
Active, not recruiting
300
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Mount Sinai Hospital; Oncology
According to Clinical.Site data, the most researched conditions in "Mount Sinai Hospital; Oncology" are
"Gastric Cancer" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Mount Sinai Hospital; Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Mount Sinai Hospital; Oncology
Most popular intervention types in "Mount Sinai Hospital; Oncology" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "5-Fluorouracil" (1 trials), "Alectinib" (1 trials), "Capecitabine" (1 trials), "Cisplatin" (1 trials) and "Crizotinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Mount Sinai Hospital; Oncology
The vast majority of trials in "Mount Sinai Hospital; Oncology" are
2 trials for "All" genders.
Clinical Trials Status at Mount Sinai Hospital; Oncology
Currently, there are NaN active trials in "Mount Sinai Hospital; Oncology".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Mount Sinai Hospital; Oncology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Mount Sinai Hospital; Oncology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".